I agree that this site is using cookies. You can find further informations here.
X
Villalona-Calero, Miguel A.
159  results:
Search for persons X
?
1

Atezolizumab combined with immunogenic salvage chemoimmunot..:

Othman, Tamer ; Frankel, Paul ; Allen, Pamela...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
2

Integrating Early-Stage Drug Development with Clinical Netw..:

Villalona-Calero, Miguel A. ; Malhotra, Jyoti ; Chung, Vincent...
Journal of Clinical Medicine.  12 (2023)  12 - p. 4061 , 2023
Link: https://doi.org/10.3390/..
 
?
3

Order of patient entry and outcomes in phase II clinical tr..:

Behrendt, Carolyn E. ; Villalona-Calero, Miguel A. ; Newman, Edward M..
Contemporary Clinical Trials.  125 (2023)  - p. 107083 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Stereotactic Body Radiation Therapy for Oligoprogressive an..:

Ebadi, Maryam ; Ladbury, Colton ; Liu, Jason...
Clinical Lung Cancer.  24 (2023)  7 - p. 651-659 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Ablative Radiotherapy as a Strategy to Overcome TKI Resista..:

Novak, Jennifer ; Salgia, Ravi ; West, Howard...
Cancers.  14 (2022)  16 - p. 3983 , 2022
Link: https://doi.org/10.3390/..
 
?
6

Clinical Outcomes for Plasma-Based Comprehensive Genomic Pr..:

Page, Ray D. ; Drusbosky, Leylah M. ; Dada, Hiba...
Clinical Lung Cancer.  23 (2022)  1 - p. 72-81 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Pembrolizumab activity in patients with Fanconi anemia repa..:

Villalona-Calero, Miguel A. ; Diaz, John P. ; Duan, Wenrui...
Biomarker Research.  10 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
8

Adjunctive PD-1 inhibitor versus standard chemotherapy in r..:

Polintan, Edgar Theodore ; Canicula, Stephanie Krystel ; Catahay, Jesus Alfonso...
Therapeutic Advances in Medical Oncology.  14 (2022)  - p. 175883592211374 , 2022
Link: https://doi.org/10.1177/..
 
?
9

Fanconi anemia repair pathway as a predictor of anti-tumor ..:

Diaz, John ; Duan, Wenrui ; Gatcliffe, Troy...
Gynecologic Oncology.  162 (2021)  - p. S66-S67 , 2021
Link: https://doi.org/10.1016/..
 
?
10

MiRNA-200C expression in Fanconi anemia pathway functionall..:

Duan, Wenrui ; Tang, Shirley ; Gao, Li...
Scientific Reports.  11 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
11

The oncogenic potential of a mutant TP53 gene explored in t..:

Ramelow, Julian ; Brooks, Christopher D. ; Gao, Li...
BMC Cancer.  20 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
12

EML4-ALK Rearrangement and Its Therapeutic Implications in ..:

Vargas-Madueno, Fernando ; Gould, Edwin ; Valor, Raul...
The Oncologist.  23 (2018)  10 - p. 1127-1132 , 2018
Link: https://doi.org/10.1634/..
 
?
13

Incidence, Risk Factors, and Effect on Survival of Immune-r..:

Owen, Dwight H. ; Wei, Lai ; Bertino, Erin M....
Clinical Lung Cancer.  19 (2018)  6 - p. e893-e900 , 2018
Link: https://doi.org/10.1016/..
 
?
14

Phase II randomized, double-blind, placebo-controlled study..:

Monk, Paul ; Liu, Glenn ; Stadler, Walter M....
Investigational New Drugs.  36 (2018)  5 - p. 919-926 , 2018
Link: https://doi.org/10.1007/..
 
?
15

Predicting response to checkpoint inhibitors in melanoma be..:

Morrison, Carl ; Pabla, Sarabjot ; Conroy, Jeffrey M....
Journal for ImmunoTherapy of Cancer.  6 (2018)  1 - p. , 2018
Link: https://doi.org/10.1186/..
 
1-15